The customer reported via phone call that they were experiencing high blood glucose.Blood glucose level at the time of the incident was 400 mg/dl.The customer's current blood glucose level was 260 mg/dl.Customer stated that the insulin inpen was not dispensing the full dose.Customer was treated with manual injection for high blood glucose.Customer also reported that the inpen was broken.Customer also reported nausea, vomiting, abdominal pain due to high blood glucose.The insulin inpen will be returned for analysis.Frn-unk-rsvr, unomed set.
|
Serial number:(b)(6).Software version: 3.8.5.Color: blue.Battery life remaining: 11 months.Customer reports: the dose button won't go past 0.1.Even if i want 4.0 units it won't do it.I used it before and it worked, but now it doesn't.Per visual inspection: no physical damage to inpen noted.The inpen paired with commercial mobile app with a 2.0u dose.The inpen screw retracts when dialing and advances when turning dose knob and high resistance while dispensing and dialing noted.High resistance dialing and dosing after 3.0 units.The dose button was removed and no dust / debris under the dose button or dose knob noted.Inpen was cut open and after inspection it was found that the encoder pattern wheel tabs rotating and traveling off the keyed slots of dose nut guides.Encoder pattern wheel should never rotate.This causes an unexpected travel of the encoder pattern wheel creating resistance to dial and dispensing.Also contamination build up found caused by encoder wheel tabs rubbing at the walls of the dose nut.In conclusion: it was determined complaint of hard to turn the inpen, hard to dial, hard to push to give insulin was confirmed due to encoder pattern wheel rotating and traveling against the walls of the dose nut.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|